ANI Pharmaceuticals (ANIP)

[Just the facts maam]

I find it interesting that Simply Wall Street pegs ANIP's Fair Value (FV) PPS, when looking at discounted cash flow, at $466.43. Obviously that is not what we can expect, but I found it interesting how it compared other pharma/biotechs on a PPS basis. ANIP was deemed more valuable than AbbVie (FW of $426.25), JNJ (FV $328.10), BIIB (FV $441.01) and NBIX (FV $388.59). Looking at what the other companies are trading, once the manipulation has reduced and a partner is announced +$150 PPS is a possibility.

These comparators appear to exclude Libigel. Just to give you an idea of where ANIP should be trading.